RHABDOMYOSARCOMA OF THE HEAD AND NECK IN CHILDREN.
D000293:Adolescent; D002648:Child; D003520:Cyclophosphamide; D003609:Dactinomycin; D005153:Facial Neoplasms; D005158:Facial Paralysis; D006257:Head; D006258:Head and Neck Neoplasms; D006801:Humans; D007223:Infant; D007568:Jaw; D008339:Mandibular Neoplasms; D016685:Mitomycin; D009303:Nasopharyngeal Neoplasms; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy*; D010336:Pathology; D011183:Postoperative Complications; D011379:Prognosis; D012208:Rhabdomyosarcoma; D014116:Toxicology; D014747:Vinblastine; D015050:Zygoma
D003609:Dactinomycin; D016685:Mitomycin; D014747:Vinblastine; D003520:Cyclophosphamide
ACTINOMYCIN; ADOLESCENCE; CHILD; CYCLOPHOSPHAMIDE; FACIAL NEOPLASMS; FACIAL PARALYSIS; HEAD; INFANT; JAW; MANDIBULAR NEOPLASMS; MITOMYCIN; NASOPHARYNGEAL NEOPLASMS; NECK NEOPLASMS; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RHABDOMYOSARCOMA; TOXICOLOGIC REPORT; VINBLASTINE; ZYGOMA